Hoth Therapeutics, Inc. 8-K

What Happened
On April 22, 2026, Hoth Therapeutics, Inc. filed Articles of Incorporation with the Nevada Secretary of State to form a wholly‑owned subsidiary named Rocket One Inc. The company said Rocket One was formed to acquire, own and operate assets related to the space industry, including nano rocket systems for deployment of nanosatellites. The disclosure was made on Form 8‑K (Item 8.01) and includes the company’s standard cautionary language about forward‑looking statements.

Key Details

• Articles of Incorporation filed: April 22, 2026 (Nevada Secretary of State).
• New subsidiary: Rocket One Inc., wholly owned by Hoth Therapeutics.
• Stated purpose: Acquire, own and operate space‑industry assets, including nano rocket systems for deploying nanosatellites.
• No financial terms, timelines, or operational details disclosed in the 8‑K.

Why It Matters
This filing signals Hoth’s planned expansion into the space industry via a dedicated subsidiary, which could broaden the company’s business scope and risk profile. Investors should note the company provided no financing, acquisition amounts, or operational milestones in the 8‑K and emphasized that these plans are forward‑looking and subject to the risks described in its 2025 Form 10‑K and other SEC filings. Watch for future filings for material agreements, financing, or other developments related to Rocket One.